Cyclin-dependent kinase 5 phosphorylates and induces the degradation of ataxin-2

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Spinocerebellar ataxia type 2 (SCA2) is caused by polyQ repeat expansion in ataxin-2.
• The physiological functions and precise pathological mechanisms of ataxin-2 remain largely unknown.
• Ataxin-2 contains numerous proline-directed phosphorylation sites, suggesting regulation by proline-directed kinases like Cdk5.

Purpose of the Study:

• To investigate whether ataxin-2 is phosphorylated by cyclin-dependent kinase 5 (Cdk5).
• To determine the effect of Cdk5-mediated phosphorylation on ataxin-2 protein stability and degradation.
• To explore the potential of Cdk5 as a therapeutic target for SCA2.

Main Methods:

• In vitro (32)P labeling assays to detect ataxin-2 phosphorylation.
• Phos-tag SDS-PAGE to assess electrophoretic mobility shifts indicative of phosphorylation.
• Expression and fractionation of ataxin-2 fragments (N-terminal, middle, C-terminal) in COS-7 cells.
• Analysis of Cdk5-mediated phosphorylation and subsequent proteasomal degradation of normal and polyQ-expanded ataxin-2.

Main Results:

• Cdk5-p25 directly phosphorylates ataxin-2, confirmed by in vitro labeling and mobility shifts.
• Cdk5-p25 phosphorylates the N-terminal and middle fragments of ataxin-2, inducing their degradation.
• Phosphorylation by Cdk5 promotes the proteasomal degradation of toxic ataxin-2 with polyQ expansion (ataxin-2-41Q).

Conclusions:

• Cdk5 plays a critical role in controlling the protein abundance of both normal and polyQ-expanded ataxin-2.
• Cdk5-mediated phosphorylation influences ataxin-2 stability and degradation pathways.
• Targeting Cdk5 activity presents a potential therapeutic strategy for managing SCA2.